NASDAQ

Latest press releases

  • LONDON and RALEIGH, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces Mr. Andrew Fisher has today joined the Company as General Counsel, and member of the Executive Management Team. Mr.

IR contacts

Verona Pharma
E: IR@veronapharma.com

US Investor relations contact
Argot Partners
E: verona@argotpartners.com
T:+1 212-600-1902

European Investor relations contact
Optimum Strategic Communications
E: verona@optimumcomms.com
T:  +44 (0)203 882 9621